Meningiomas: skull base versus non-skull base
- 97 Downloads
To identify differences between skull base meningiomas (SBM) and non-skull base meningiomas (NSBM). All adult patients (18.0–69.9 years) operated for intracranial meningiomas between 1990 and 2010 at our institution were investigated. Al-Mefty’s definition was used to dichotomize tumors into SBM and NSBM. Overall, 1148 consecutive patients were identified. Median age at surgery was 54.2 years [18.1–69.9]. Median follow-up was 7.4 years [0.0–20.9]. There were 562 patients (49%) with SBM and 586 (51%) with NSBM. The two groups were similar with respect to patient age, follow-up time, and number of patients. Overall female-to-male ratio was 2.6:1, but 3.2:1 in SBM and 2.2:1 in NSBM (p < 0.005). With respect to presenting symptoms, SBMs had more often neurological deficits (risk ratio (RR) 1.4; p < 0.0001) and less often seizures (RR 0.4; p < 0.0001). Gross total resections were less frequent in SBM than NSBM (62 vs 84%) (RR 1.3; p < 0.0001). SBMs had a lower risk of WHO grades II and III histology (4.5 vs 9.5%) (RR 0.5; p < 0.001). Worsening of neurological function was more frequent in SBM (21 vs 121%) (RR 1.8; p < 0.001). Retreatment-free survival at 5, 10, and 15 years, respectively, was 80, 70, and 62% for SBM versus 90, 82, and 74% for NSBM (p < 0.0001). Overall survival at 5, 10, and 15 years, respectively, was 93, 85, and 78% for SBM and 96, 91, and 79% for NSBM (p = 0.14). Patients with SBMs had more new-onset neurological deficits and significantly shorter retreatment-free survivals, but this did not adversely affect the overall survival.
KeywordsCraniotomy Intracranial tumor Meningioma Retreatment-free survival Overall survival
The authors would like to thank Bernt Filip Hasseleid, MD; Andreas Mathisen, MD; Andreas Hessen Schei, MD; and Kristina M Ødegaard, MD, for their valuable contributions in collecting data for this manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
For this type of study, formal consent is not required.
- 5.Black PM, Morokoff AP, Zauberman J (2008) Surgery for extra-axial tumors of the cerebral convexity and midline. Neurosurgery 62:1115–1121; discussion 1121-1113. https://doi.org/10.1227/01.neu.0000333778.66316.38 CrossRefPubMedGoogle Scholar
- 13.D’Amico RS, Banu MA, Petridis P, Bercow AS, Malone H, Praver M, Wang TJC, Isaacson SR, Sisti MB (2017) Efficacy and outcomes of facial nerve-sparing treatment approach to cerebellopontine angle meningiomas. J Neurosurg 127:1231–1241. https://doi.org/10.3171/2016.10.jns161982 CrossRefPubMedGoogle Scholar
- 15.DeMonte F, McDermott MW, Al-Mefty O (2011) Al-Mefty’s meningiomas, 2nd edn. Thieme Medical, New YorkGoogle Scholar
- 24.Kshettry VR, Ostrom QT, Kruchko C, Al-Mefty O, Barnett GH, Barnholtz-Sloan JS (2015) Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States. Neuro-Oncology 17:1166–1173. https://doi.org/10.1093/neuonc/nov069 CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Lassen B, Helseth E, Ronning P, Scheie D, Johannesen TB, Maehlen J, Langmoen IA, Meling TR (2011) Surgical mortality at 30 days and complications leading to recraniotomy in 2630 consecutive craniotomies for intracranial tumors. Neurosurgery 68:1259–1268; discussion 1268-1259. https://doi.org/10.1227/NEU.0b013e31820c0441 CrossRefPubMedGoogle Scholar
- 27.Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1 CrossRefPubMedGoogle Scholar
- 28.Mansouri A, Klironomos G, Taslimi S, Kilian A, Gentili F, Khan OH, Aldape K, Zadeh G (2016) Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas. J Neurosurg 125:431–440. https://doi.org/10.3171/2015.7.jns15546 CrossRefPubMedGoogle Scholar
- 30.Modha A, Gutin PH (2005) Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 57:538–550; discussion 538-550. https://doi.org/10.1227/01.NEU.0000170980.47582.A5 CrossRefPubMedGoogle Scholar
- 31.Morokoff AP, Zauberman J, Black PM (2008) Surgery for convexity meningiomas. Neurosurgery 63:427–433; discussion 433-424. https://doi.org/10.1227/01.neu.0000310692.80289.28 CrossRefPubMedGoogle Scholar
- 34.Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2016) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013. Neuro-Oncology 18:v1–v75. https://doi.org/10.1093/neuonc/now207 CrossRefPubMedGoogle Scholar
- 35.Otero-Rodriguez A, Tabernero MD, Munoz-Martin MC, Sousa P, Orfao A, Pascual-Argente D, Gonzalez-Tablas M, Ruiz-Martin L (2016) Re-evaluating Simpson grade I, II, and III resections in neurosurgical treatment of World Health Organization grade I meningiomas. World Neurosurg 96:483–488. https://doi.org/10.1016/j.wneu.2016.09.007 CrossRefPubMedGoogle Scholar
- 40.Savardekar AR, Patra DP, Bir S, Thakur JD, Mohammed N, Bollam P, Georgescu MM, Nanda A (2017) Differential tumor progression patterns in skull base versus non-skull base meningiomas: a critical analysis from a long-term follow-up study and review of literature. World Neurosurg. https://doi.org/10.1016/j.wneu.2017.12.035
- 42.Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. doi: https://doi.org/10.1136/jnnp.20.1.22
- 45.Sughrue ME, Kane AJ, Shangari G, Rutkowski MJ, McDermott MW, Berger MS, Parsa AT (2010) The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. J Neurosurg 113:1029–1035. https://doi.org/10.3171/2010.3.jns091971 CrossRefPubMedGoogle Scholar
- 46.Talacchi A, Biroli A, Soda C, Masotto B, Bricolo A (2012) Surgical management of ventral and ventrolateral foramen magnum meningiomas: report on a 64-case series and review of the literature. Neurosurg Rev 35:359–367; discussion 367-358. https://doi.org/10.1007/s10143-012-0381-6 CrossRefPubMedGoogle Scholar
- 48.Voss KM, Spille DC, Sauerland C, Suero Molina E, Brokinkel C, Paulus W, Stummer W, Holling M, Jeibmann A, Brokinkel B (2017) The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value? J Neuro-Oncol 133:641–651. https://doi.org/10.1007/s11060-017-2481-1 CrossRefGoogle Scholar
- 49.Waldron JS, Sughrue ME, Hetts SW, Wilson SP, Mills SA, McDermott MW, Dowd CF, Parsa AT (2010) Embolization of skull base meningiomas and feeding vessels arising from the internal carotid circulation. Neurosurgery 68:162–169; discussion 169. https://doi.org/10.1227/NEU.0b013e3181fe2de9 CrossRefGoogle Scholar
- 52.Zouaoui S, Darlix A, Rigau V, Mathieu-Daude H, Bauchet F, Bessaoud F, Fabbro-Peray P, Tretarre B, Figarella-Branger D, Taillandier L, Loiseau H, Bauchet L (2015) Descriptive epidemiology of 13,038 newly diagnosed and histologically confirmed meningiomas in France: 2006-2010. Neuro-Chirurgie 64:15–21. https://doi.org/10.1016/j.neuchi.2014.11.013 CrossRefGoogle Scholar